| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 216390 | 001 | ANDA | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | INJECTABLE;INJECTION | 500MG/VIAL | No | No | 2022/12/23 | 2022/12/23 | STERISCIENCE SPECLTS | Prescription |
| MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 214283 | 001 | ANDA | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | INJECTABLE;INJECTION | 500MG/VIAL | No | No | 2023/06/01 | 2023/06/01 | BPI LABS | Prescription |
| MYCOPHENOLATE MOFETIL | 212634 | 001 | ANDA | MYCOPHENOLATE MOFETIL | FOR SUSPENSION;ORAL | 200MG/ML | No | No | 2023/08/29 | 2023/08/29 | STRIDES PHARMA | Prescription |
| MYCOPHENOLATE MOFETIL | 213955 | 001 | ANDA | MYCOPHENOLATE MOFETIL | FOR SUSPENSION;ORAL | 200MG/ML | No | No | 2023/09/11 | 2023/09/11 | RISING | Prescription |
| MYCOPHENOLATE MOFETIL | 217828 | 001 | ANDA | MYCOPHENOLATE MOFETIL | CAPSULE;ORAL | 250MG | No | No | 2024/01/05 | 2024/01/05 | AUROBINDO PHARMA LTD | Prescription |
| MYCOPHENOLATE MOFETIL | 217937 | 001 | ANDA | MYCOPHENOLATE MOFETIL | TABLET;ORAL | 500MG | No | No | 2024/02/20 | 2024/02/20 | AUROBINDO PHARMA | Prescription |
| MYCOPHENOLATE MOFETIL | 218227 | 001 | ANDA | MYCOPHENOLATE MOFETIL | FOR SUSPENSION;ORAL | 200MG/ML | No | No | 2024/09/26 | 2024/09/26 | AUROBINDO PHARMA LTD | Prescription |
| MYCOPHENOLATE MOFETIL | 207022 | 001 | ANDA | MYCOPHENOLATE MOFETIL | CAPSULE;ORAL | 250MG | No | No | 2024/10/22 | 2024/10/22 | HETERO LABS LTD V | Prescription |
| MYCOPHENOLATE MOFETIL | 208119 | 001 | ANDA | MYCOPHENOLATE MOFETIL | TABLET;ORAL | 500MG | No | No | 2024/10/22 | 2024/10/22 | HETERO LABS LTD V | Prescription |
| MYCOPHENOLATE MOFETIL | 214079 | 001 | ANDA | MYCOPHENOLATE MOFETIL | CAPSULE;ORAL | 250MG | No | No | 2024/11/07 | 2024/11/07 | WUXI | Prescription |